NewsMunchies

MAY 8, 2023

In 2018, I was a Presenter at a Hillsborough County Bar Association event for a group of judges after Florida passed its limited medical marijuana bill. Access to medical marijuana is protected under the Florida Constitution since the passage of Amendment 2 was approved in the vast majority of counties beyond the necessary threshold.

Law 81

Law Marijuana Conditions Epilepsy 81

Veriheal

FEBRUARY 28, 2021

It helps to showcase the 103 countries holding events on this day as well as the thousands of events hosted online worldwide. This year, COVID-19 has dramatically impacted the way events are hosted. Instead of having physical locations, many events have opted to go digital being held online.

Chronic Pain 52

Chronic Pain Events Therapy Treatment 52

SpeedWeed

APRIL 2, 2021

The legacy of Charlotte Figi, the young Colorado girl whose struggle with epilepsy made CBD known worldwide, will be remembered next week with a benefit concert taking place in her honor. She had a rare form of epilepsy known as Dravet syndrome that caused dozens or even hundreds of seizures per day. A Benefit For Realm Of Caring.

Events 52

Events Epilepsy Cannabinoids Treatment 52

Cannabis Law Report

DECEMBER 7, 2021

While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events. Adverse mental events were reported as well, however, more research should be performed to assess well this outcome. 1.69, 95% CI [1.20–2.36])

Safety 52

Safety Cannabinoids Events Data 52

MMJ Recs

APRIL 15, 2022

Having a valid Missouri MMJ card guarantees you legal and safe access to medical cannabis products to help manage or treat your symptoms. MMJ patient drives are a vital initiative that improves access to MMJ cards in Missouri by catering to those who may otherwise find it difficult to travel to urban centers for their consultation.

Patients 52

Patients Chronic Pain Dispensary Conditions 52

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? PDF Version.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

AUGUST 17, 2021

We look forward to initiating our Phase 3 trial and adding to the body of evidence that supports ganaxolone’s potential as an innovative treatment option for rare epilepsies.”. The live webcast can be accessed here and on the investor page of Marinus’ website. Chief Medical Officer of Marinus. “We Data Highlights. 484-253-6792.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. By utilizing the Ohio Medical Marijuana Dispensaries Map, patients can confidently explore their options and access quality medical cannabis products.

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

MARCH 2, 2020

The UK government has eased import restrictions on medicinal cannabis, but has admitted it needs to do much more to improve access for patients. In November last year, the National Institute for Health and Care Excellence (NICE) recommended 2 cannabis-based medicinal products for patients with multiple sclerosis and hard-to-treat epilepsies.

Medicine 59

Medicine Research and Development Clinical Trials Patients 59

MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Medical marijuana requires a doctor’s recommendation and provides certain advantages, including lower taxes and access to a broader range of products.

Dispensary 52

Dispensary Patients Environment Conditions 52

MMJ Recs

MARCH 25, 2022

MMJ patient drives can help more people to access the medical marijuana they need. Patient drives are like pop-up day events, during which many people can avail of quick and easy appointments for MMJ cards if they have a qualifying condition. What is a NY patient drive? So, what is a New York patient drive ?

Patients 52

Patients Conditions Chronic Pain Dispensary 52

SpeedWeed

MAY 5, 2021

Last week was eventful for cannabis reform in Texas, as the House of Representatives approved three legislative proposals, which would expand the state’s medical cannabis program, reduce penalties for concentrates and decriminalize possession. 1535 would also raise the THC limit in medical cannabis from 0.5%

Programs 52

Programs Chronic Pain Concentrates THC 52

SpeedWeed

MAY 4, 2021

Last week was eventful for cannabis reform in Texas, as the House of Representatives approved three legislative proposals, which would expand the state’s medical cannabis program, reduce penalties for concentrates and decriminalize possession. 1535 would also raise the THC limit in medical cannabis from 0.5%

Programs 52

Programs Chronic Pain Concentrates THC 52

CannaMD

SEPTEMBER 15, 2020

MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. Once you begin medical marijuana treatment, the only people that will have access to your records will be: Your doctor. Crohn’s Disease.

Law 126

Law Marijuana Patients Treatment 126

WeedAdvisor

MARCH 29, 2019

While CBD was already well-known to many medical users, those with only recreational access quickly fell into the hype. The most extensive research involved patients with severe – often untreatable – epilepsy. Following successful trials for children with LGS and Dravet Syndrome, the U.S.

Oil 40

Oil CBD Research and Development Epilepsy 40

Veriheal

OCTOBER 5, 2020

This bill also allows for dispensaries to “provide, disseminate, and publish educational and scientific material related to medical cannabis and its approved products and sponsor events about medical cannabis”. . Summary of Hawaiian Cannabis Regulations. Act 228 allows for the growth of cannabis for medical purposes. .

Edibles 52

Edibles Legalization Decriminalization Consumption 52

Puff Puff Post

MARCH 2, 2020

tonnes approved, 50% are for Colombian domestic use and 50% are allowed for export purposes. · Export quotas allow for the manufacture of whole plant extract for international purposes to countries such as Peru, Uruguay, and Brazil, thereby accessing to a medical cannabis market of $1.4 . · Of the 9.3 United States Disclaimer.

Extraction 52

Extraction THC Chronic Pain Cultivation 52

Cannabis Law Report

DECEMBER 1, 2021

Because it can cross the blood-brain barrier and gain access to the central nervous system (CNS), MYMD-1 is also positioned to be a possible treatment for brain-related disorders. The Company believes that Supera-CBD is currently on a path toward human clinical trials as a therapy for epilepsy, followed by chronic pain. Robert Schatz.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

JANUARY 13, 2020

commercial and government payors to ensure that appropriate patients have access to Epidiolex with as few restrictions as possible. GW undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise. Work with U.S.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Accessed July 25, 2021. Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JANUARY 20, 2022

Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Medicines and Healthcare products Regulatory Agency’s Innovative Licensing and Access Pathway (“ILAP”), offering the potential to accelerate time to market.

Therapy 52

Therapy Research and Development Business Access 52

Puff Puff Post

MARCH 2, 2020

tonnes approved, 50% are for Colombian domestic use and 50% are allowed for export purposes. · Export quotas allow for the manufacture of whole plant extract for international purposes to countries such as Peru, Uruguay, and Brazil, thereby accessing to a medical cannabis market of $1.4 . · Of the 9.3 United States Disclaimer.

Extraction 40

Extraction THC Chronic Pain Cultivation 40

Sensi Seeds

JANUARY 7, 2019

As a long-time cannabis activist, entrepreneur and educator in a career spanning 40 years, today DeAngelo is the CEO of Harborside Health Center in Oakland, California, and a regular speaker at international industry events.

Education 94

Education Dispensary Media Cannabis 94

The Joint Blog

MARCH 9, 2022

Experts and specialists endorse them to treat extreme epilepsy and chemotherapy side effects. A vast scope study on the utilization of weed in the treatment of pediatric epilepsy observed that weed reduces seizures frequency by over half in 43% of the patients with Dravet syndrome. There are two synthetic adaptations of marijuana.

Sleep 26

Sleep Treatment Conditions Epilepsy 26

Cannabis Law Report

NOVEMBER 23, 2021

Because it can cross the blood-brain barrier and gain access to the central nervous system (CNS), MYMD-1 is also positioned to be a possible treatment for brain-related disorders. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. MyMD Contact: Robert Schatz.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Chronic Pain 52

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. Prior to joining Sesen Bio, Mr. Barbera served as the Vice President of Market Access at UroGen Pharma and played a critical role in the launch of the company’s first commercial product, Jelmyto ®. Julie Hoff to Vice President, Human Resources.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

JANUARY 5, 2022

Because it can cross the blood-brain barrier and gain access to the central nervous system (CNS), MYMD-1 is also positioned to be a possible treatment for brain-related neurodegenerative and neuroinflammatory disorders. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Cannabis Law Report

NOVEMBER 16, 2021

Because it can cross the blood-brain barrier and gain access to the central nervous system (CNS), MYMD-1 is also positioned to be a possible treatment for brain-related disorders. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. MyMD Contact: Robert Schatz.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

MAY 6, 2022

Generally, a CBD product seller is expected (or required by law) to provide customers with access to a “certificate of analysis” or “COA” associated with specific products, which COA confirms the levels of CBD in products and upon which customers can rely. High level CBD can help manage symptoms of psychosis.”.

THC 52

THC CBD Media Food 52

Puff Puff Post

NOVEMBER 30, 2018

They want to push for access to CBD oil to treat sick animals. Our pets also develop chronic diseases and illnesses like cancer and epilepsy. Of note, if his anxiety and behavioral problems are related to an event (fireworks or traveling), given him CBD oil at least half an hour before the event.

Pets 76

Pets Oil CBD Research and Development 76

Cannabis Law Report

OCTOBER 24, 2019

It will allow for regulated, supervised and limited access for our sick citizens especially those with cancer, HIV/ AIDS, glaucoma, and epilepsy. Politicians are listening closely to the public discussions and consultations being raised at Cannabis educational events about how to move forward. The oils can be legally imported.

Law 45

Law Medicine Decriminalization Oil 45

Cannabis Law Report

JANUARY 27, 2020

The US Food and Drug Administration (FDA) asserts its case clearly on its website, emphasising that it has approved only one product, and that’s a prescription drug to treat two rare forms of epilepsy. Video News Event Campaign All . Inevitably, this is an area we’re watching very closely. Related Content.

Safety 59

Safety CBD Food Seed-To-Sale 59

Cannabis Law Report

SEPTEMBER 23, 2019

Surveying marijuana use is essential to gauge public health implications of increased access to marijuana, cannabinoid, and cannabis products. People who are incarcerated have significantly higher rates of disease than those who are not, and are less likely to have access to adequate medical care. Accessed August 20, 2019.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

The Cannigma

MAY 7, 2021

The Cannabis Enigma podcast is a co-production of The Cannigma and Americans for Safe Access. You’ve had this conversation in the US for over 20 years in some states so it’s not as if suddenly overnight, people have woken up to the discussion of cannabis and cannabis legalization and cannabis access. Music by Desca.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.

Research and Development 52

Research and Development Medicine Access Media 52

CannaTech

JUNE 30, 2019

These include changes to reduce barriers to patient access, specific licensing requirements for production, and expanding the number of access points approved of sale. Patients over the age of 18 (excepting children with severe epilepsy). Neurological indications such as epilepsy, Parkinson’s.

Patients 90

Patients Oil Epilepsy Strains 90

Cannabis Law Report

OCTOBER 1, 2021

The presentation can be accessed by registering (at no cost) for the Investor Forum at www.channelchek.com ; the investor portal created by Noble. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Eastern time. Channelchek (.com)

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Chronic Pain 52